Skip to main content

Brain study finds a molecular “off” switch for nicotine craving

In findings that might lead to better smoking-cessation tools, scientists have shown that manipulating a specific brain receptor can alter a mouse’s nicotine sensitivity.

Rockefeller’s 62nd Convocation to be held virtually this week

The spirit of the occasion will be preserved as this year’s usual in-person event is replaced with a virtual ceremony.

Rockefeller statement calls for justice and inclusivity in the United States

Read the Office of the President’s message to the campus community.

Unique mutation reveals a new role for well-known DNA-repair gene

The discovery of a rare mutation in BRCA2, commonly known as the breast cancer gene, has shed new light on how cells safeguard their genetic material.
 

Study reveals first evidence inherited genetics can drive cancer’s spread

Scientists have long struggled to understand what drives a tumor to seed itself elsewhere in the body. New research implicates our own pre-existing genetics.

Rockefeller scientists investigate life-threatening inflammation affecting children with COVID-19

The condition resembles a rare childhood illness, Kawasaki disease. Researchers are analyzing blood samples to find genetic clues to what might be causing it.

Mice with patchy coats lay bare how stem cells endure

Scientists have discovered how stem cells in the skin maintain their ability to replenish themselves, a process critical for hair growth. The findings suggest that errors in stem cell maintenance might contribute to permanent hair-loss conditions.

The gene hunt to explain why some young, healthy people die from COVID-19

People under 50 without preexisting conditions typically develop mild symptoms of coronavirus infection—but there are exceptions. Researchers are working to identify rare genetic variations that may explain why some in this group have succumbed to the disease.

Scientists are using ‘elite’ antibodies from COVID-19 survivors to develop potent therapies

Most people infected with the coronavirus are able to fight it off because their immune system produces effective antibodies. Rockefeller scientists are working to turn such antibodies into a drug.


>

Study captures the molecular architect of cells’ infrastructure

Using atomic-resolution technology, scientists have constructed the most detailed view yet of the molecular complex that decides where microtubules form.